Patents by Inventor Mike Baker

Mike Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11424031
    Abstract: The present disclosure relates to the field of diagnostics, specifically, to a method of identifying progressing multiple sclerosis (MS) in a subject. At least one performance parameter is determined from a dataset of activity measurements obtained from the subject using a mobile device, and the performance parameter is compared to a reference, whereby a subject with progressing MS will be identified. Also disclosed is a method of recommending an anti-CD20 antibody therapy against MS that includes the steps just mentioned and the further step of recommending the anti-CD20 antibody therapy if the subject suffers from progressing MS. Also disclosed is a mobile device having a processor, at least one sensor and a database as well as software which is tangibly embedded to the device and, when running on said device, carries out the method of this disclosure as well as the use of such a device for identifying a subject suffering from progressing MS.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: August 23, 2022
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Mike Baker, Shibeshih Mitiku Belachew, Christian Gossens, Michael Lindemann
  • Publication number: 20210059572
    Abstract: A method for automatically assessing information processing speed in a test subject is disclosed. In the inventive method, a first qualimetric activity parameter for sensorial transmission, cognition and motoric output activity is determined and a second qualimetric activity parameter for sensorial transmission and motoric output activity is determined. A third qualimetric activity parameter for cognition is determined by comparing the first and the second qualimetric activity parameters to each other, and the information processing speed in the test subject is assessed based on the first, second and third qualimetric activity parameters. The information processing speed can be determined by comparing the determined qualimetric activity parameters to a reference and the subject's cognitive impairment can then be determined from the processing speed. The inventive method can be computer implemented. A mobile device or system for carrying out the disclosed methods is also disclosed.
    Type: Application
    Filed: November 7, 2020
    Publication date: March 4, 2021
    Inventors: Mike Baker, Shibeshih Mitiku Belachew, Christian Gossens, Michael Lindemann, Jörg Sprengel
  • Publication number: 20200258631
    Abstract: Disclosed is a method for assessing a cognition and movement disease or disorder in a subject. In the method, a qualimetric activity parameter for cognition and/or fine motoric activity measurements is determined from a dataset of measurements obtained from the subject using a mobile device. The qualimetric activity parameter is compared to a reference and the disease or disorder is thereby assessed. A method identifying whether a subject will benefit from a therapy for a cognition and movement disease or disorder is also disclosed. The method can be carried out with a mobile device having a processor, a sensor and a database as well as software that carries out the method. Also disclosed is a system having a mobile device with a sensor and a remote device having a processor and a database and software that carries out the method for assessing a cognition and movement disease or disorder.
    Type: Application
    Filed: April 23, 2020
    Publication date: August 13, 2020
    Inventors: Mike Baker, Shibeshih Mitiku Belachew, Christian Gossens, Michael Lindemann, Jörg Sprengel
  • Publication number: 20190214140
    Abstract: The present disclosure relates to the field of diagnostics, specifically, to a method of identifying progressing multiple sclerosis (MS) in a subject. At least one performance parameter is determined from a dataset of activity measurements obtained from the subject using a mobile device, and the performance parameter is compared to a reference, whereby a subject with progressing MS will be identified. Also disclosed is a method of recommending an anti-CD20 antibody therapy against MS that includes the steps just mentioned and the further step of recommending the anti-CD20 antibody therapy if the subject suffers from progressing MS. Also disclosed is a mobile device having a processor, at least one sensor and a database as well as software which is tangibly embedded to the device and, when running on said device, carries out the method of this disclosure as well as the use of such a device for identifying a subject suffering from progressing MS.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 11, 2019
    Inventors: Mike Baker, Shibeshih Mitiku Belachew, Christian Gossens, Michael Lindemann
  • Publication number: 20190200915
    Abstract: A method for assessing a cognition and movement disease or disorder in a subject suspected to suffer therefrom. A cognition and/or fine motoric activity parameter is determined from a dataset of activity measurements obtained from the subject using a mobile device. The determined activity parameter is compared to a reference, and the cognition and movement disease or disorder is assessed. Also disclosed is a method for identifying whether a subject will benefit from a therapy for a cognition and movement disease or disorder. The steps just described are performed along with the step of identifying the subject as one who benefits from the therapy if the cognition and movement disease or disorder is assessed. Also disclosed is a mobile device comprising a processor, at least one sensor, a database and software which is tangibly embedded in said device and, when running on said device, carries out the disclosed methods.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 4, 2019
    Inventors: Mike Baker, Shibeshih Mitiku Belachew, Christian Gossens, Michael Lindemann
  • Patent number: 7100577
    Abstract: A common rail directly actuated fuel injection valve is disclosed with a hydraulic transmission device that is fluidly isolated from the fuel so that the hydraulic fluid can be different from the fuel. This arrangement is particularly suitable for valves that inject a gaseous fuel, but can also be beneficial for use with liquid fuels. According to the method, the hydraulic fluid is pressurizable by the fuel pressure to reduce differential pressures and leakage, in addition to assisting with operation of the hydraulic transmission device. The method further comprises detecting the position of the valve needle for more accurate control of rate of fuel injection during an injection event.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: September 5, 2006
    Assignee: Westport Research Inc.
    Inventors: David Mumford, Richard Ancimer, Mike Baker, Damien Clapa, Richard Wing
  • Publication number: 20050274360
    Abstract: A common rail directly actuated fuel injection valve is disclosed with a hydraulic transmission device that is fluidly isolated from the fuel so that the hydraulic fluid can be different from the fuel. This arrangement is particularly suitable for valves that inject a gaseous fuel, but can also be beneficial for use with liquid fuels. According to the method, the hydraulic fluid is pressurizable by the fuel pressure to reduce differential pressures and leakage, in addition to assisting with operation of the hydraulic transmission device. The method further comprises detecting the position of the valve needle for more accurate control of rate of fuel injection during an injection event.
    Type: Application
    Filed: June 14, 2004
    Publication date: December 15, 2005
    Inventors: David Mumford, Richard Ancimer, Mike Baker, Damien Clapa, Richard Wing